To support the translation of molecular imaging research into clinical practice To foster the use of...
-
Upload
melvin-rice -
Category
Documents
-
view
213 -
download
0
Transcript of To support the translation of molecular imaging research into clinical practice To foster the use of...
![Page 1: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/1.jpg)
• To support the translation of molecular imaging research into clinical practice
• To foster the use of molecular imaging in drug discovery and development
• To engage industry and the molecular imagingcommunity
• To raise $5,000,000 over 5 years
Campaign Overview
![Page 2: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/2.jpg)
Value of the Campaign• Recognizes expanding role of molecular imaging in
patient care
• Builds on SNM’s unique role in medical community
• Highlights importance of molecular imaging in drug discovery and development
• Ensures imaging practitioners are well prepared to adopt and use this technology
• Ensures medical community is well informed and partnerships are formed outside imaging field
![Page 3: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/3.jpg)
Goals of the Molecular Imaging Campaign
• Provide indispensable resources for education, knowledge exchange, training and networking
• Advocate for molecular imaging and therapy
• Educate and promote collaboration with referring physicians and patient groups
• Support innovations in translational research
• Position molecular medicine as an essential tool in providing the highest standards of patient care around the world
![Page 4: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/4.jpg)
Provide indispensable resources for education, knowledge exchange, training and networking• Be a central repository for molecular imaging
• Create and award grants and fellowships
• Develop fellowship and residency curriculum
• Conduct workshops to attract and meet diversified needs of molecular imaging practitioners
• Implement continuing educational programs and web-based training
![Page 5: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/5.jpg)
Provide indispensable resources for education, knowledge exchange, training and networking
• Support clinical trials in nuclear medicine and molecular imaging
• Implement communications plan to raise awareness that SNM is the indispensable resource for molecular imaging
![Page 6: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/6.jpg)
Advocate for molecular imaging and therapy
• Proactively lobby for reimbursement and research funding
• Strengthen relationships with federal agencies and Congress
• Educate community on benefits of molecular imaging and emerging technologies
![Page 7: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/7.jpg)
Educate and promote collaboration with referring physicians and patient groups
• Create outreach program for referring physicians, patient groups, federal agencies, regulators and the general public
![Page 8: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/8.jpg)
Support innovations in translational research• Define translational research from bench to
bedside – research to practice
• Provide institutional grants for training workshops on translating basic research into clinical application
• Develop research programs to assist new investigators in the field of molecular imaging
• Identify new funding opportunities
![Page 9: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/9.jpg)
Support innovations in translational research (cont’d)
• Develop standardized imaging protocols and outcome measures
• Define the role of biomarkers in clinical trials
• Investigate the implications of molecular imaging in diagnosis and the prediction and monitoring of treatment response
• Develop technology assessment mechanism
![Page 10: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/10.jpg)
Support innovations in translational research (cont’d)• Assure the viability of MI through the
development of techniques that meet a clinical need and that are reimbursable
• Partner with basic science organizations, academia, and industry to promote translational research
• Position SNM as a central repository for molecular imaging research
• Identify and validate new tracers
![Page 11: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/11.jpg)
SNM will be recognized as the society that positions molecular medicine as an essential tool in providing the highest standards of patient care around the world• Develop major media marketing plan to
influence the introduction and acceptance of molecular imaging technology and benefits
• Develop an integrated strategic marketing plan to position SNM as the recognized leader
• Increase membership by molecular imaging professionals outside of nuclear medicine
![Page 12: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/12.jpg)
Strategic Plan Implementation
• Molecular Imaging Center of Excellence has the lead
• Developed 9 Task Forces and Editorial Board to implement objectives/strategies for each goal
• Task Forces include members of the Center, SNM Committees and Council, and other leaders in the field
![Page 13: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/13.jpg)
Overall First Year Accomplishments• Infrastructure and capacity building
- Rebranding
- New staffing
- Governance (elections, nominating committee)
- Involvement of SNM and wider MI community
• Developed definition for molecular imaging
![Page 14: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/14.jpg)
Molecular Imaging DefinitionMolecular imaging is the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems.
– Molecular imaging typically includes two- or three- dimensional imaging as well as quantification over time.
– The techniques used include radiotracer imaging/nuclear medicine, MRI, MRS, optical imaging, ultrasound and others.
![Page 15: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/15.jpg)
Communications - Highlights• Developed new SNM & MI community Web
site
• Expanded JNM and Newsline coverage
• Created “Road Show,” Newsletter, email blasts with references
• Launched media campaign, rebranding
• Free trial membership
![Page 16: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/16.jpg)
Communications – Looking Ahead• MI Supplement
• Begin regular article series in JNMT
• Complete brochures on practical benefits
• Continue and intensify media campaign
• Develop “rapid-action” unit to respond to timely issues through op-eds, etc
• New news services, email blasts and web content
![Page 17: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/17.jpg)
Advocacy- Highlights• Launched first Capitol Hill Day and MI Week
– NCCR Briefing
• Held key Federal agency meetings (CMS, NIH, FDA, DOE, OSTP)
• Met with key associations, research organizations and companies
• Created outreach database
• Identifying new research funding sources
![Page 18: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/18.jpg)
Advocacy- Looking Ahead• Strengthen strategic partnerships
– ASTRO, ASCO meeting collaboration
– American Chemical Society, American Academy of Neurology, NIH Cardiovascular Imaging Symposium
• Conduct educational forums with coalitions and patient groups
• Increase outreach to pharmaceutical companies
• Work with NIH Advisory Councils to become official liaison
![Page 19: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/19.jpg)
Education – Highlights• Expanded MI focus at MWM, Annual Meeting, in
JNM
– Molecular Imaging Gateway
– Molecular Imaging Supplement
– New series of articles
• Recommended new clinical/research grants,awards
• Developed curriculum for residents
• Created speakers’ bureau
• Planning for more workshops, training, Summits
![Page 20: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/20.jpg)
Education – Looking Ahead• Have new MI Track at Annual Meeting
• Hold Second Industry/Expert Summit in February
• Develop training workshops and on-line tools
• Outreach to residency program directors
• Make speaker’s bureau fully operational
• Develop “MI scientist” curriculum guidelines
• Create scientific “roadshow” for chapters, others
![Page 21: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/21.jpg)
Translational Activities – Highlights• Held action planning retreat for imminently
emerging technologies in June
• Recommendations from retreat to be published in white paper
![Page 22: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/22.jpg)
Translational Activities – Looking Ahead• Continuing series of retreats to discuss key
issues
– New tracer development
– Technology assessment and advancement
– Translational research education
– Standardized imaging protocols
• Protocol and regulatory development
• Ongoing discussions with FDA
![Page 23: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/23.jpg)
MI Center of Excellence Leadership
• Martin Pomper, MD., PhD. – President
• Henry Van Brocklin, PhD – Vice-President
• Carolyn Anderson, PhD – Secretary/Treasurer
Staff• Marybeth Howlett, MEM – Staff
Director
• Communications/Web Site Editor - TBD
• Zachary Hochstetler – Program Manager
![Page 24: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/24.jpg)
Task Force Chairs
• Communications – Al Sinusas, MD
• Education – Carolyn Anderson, Ph.D
• Advocacy – Robert Atcher, Ph.D
• Grants & Awards – Mathew Thakur, Ph.D
![Page 25: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/25.jpg)
Task Force Chairs (cont’d)• Definitions – David Mankoff, MD
• Emerging Technologies – Sandy McEwan, MD
• Future Tracers– Henry VanBrocklin, PhD
• Membership – Scott Holbrook, MS CNMT NCT
![Page 26: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/26.jpg)
How to Support the Campaign
• Corporate donations and pledges
• Individual gifts and pledges
• Collaboration in task forces, summits
• Feedback and ideas
• Involvement through MI COE, Web site, list serve
![Page 27: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/27.jpg)
Financial Support
• Corporate pledges over five years or less
• Individual gifts and pledges – Education and Research Foundation
• Donor recognition began in 2006
![Page 28: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/28.jpg)
• Co-chairs of the campaign:
Hadi Moufarrej, GE Healthcare
Peter S. Conti, M.D., Ph.D.; SNM Past President
Michael D. Devous, Sr., Ph.D.; ERF Past President
• SNM Campaign staff:
Virginia Pappas; CEO
Theresa Pinkham, Development Director
Marybeth Howlett; Director, MI Center of Excellence
Campaign Leadership and Staff
![Page 29: To support the translation of molecular imaging research into clinical practice To foster the use of molecular imaging in drug discovery and development.](https://reader034.fdocuments.in/reader034/viewer/2022042821/56649d705503460f94a51eac/html5/thumbnails/29.jpg)
• Corporate Circle: $500,000 or more
• Corporate Visionary: $250,000 - $499,999
• Corporate Partner: $100,000 - $249,999
• Corporate Friend: $50,000 - $99,999
• Corporate Contributor: <$50,000
Industry Donor Categories